November 17, 2026
Business

Delhi HC allows Dr Reddy’s to make semaglutide for export, rejects appeal(Soban News)

The Delhi High Court has upheld an order permitting Dr Reddy’s Laboratories to manufacture semaglutide in India solely for export, rejecting Novo Nordisk’s appeal in the ongoing patent dispute

​The Delhi High Court has upheld an order permitting Dr Reddy’s Laboratories to manufacture semaglutide in India solely for export, rejecting Novo Nordisk’s appeal in the ongoing patent dispute by Soban News (international And National News)

Related posts

South Africa Banks Pan Minister’s U-Turn on Credit-Law Changes(Soban News)

News-Soban-Admin

Trader’s guide to navigating supply disruption by war(Soban News)

News-Soban-Admin

Standard Chartered Bank settles Sebi case over FPI lapses(Soban News)

News-Soban-Admin

Leave a Comment